C-type lectin domain family 16 member A (CLEC16A)

CLEC16A (C-type lectin domain family 16 member A) is a large, highly conserved protein encoded by the CLEC16A gene, originally classified as a C-type lectin but now understood to function primarily as an E3 ubiquitin ligase involved in mitochondrial quality control via mitophagy[1][2]. CLEC16A forms complexes with RNF41 (Nrdp1) and USP8 to regulate mitochondrial clearance, especially in pancreatic β-cells, and its stability is critically determined by a C-terminal intrinsically disordered region enriched in proline residues[1]. CLEC16A is especially expressed in immune cells (B-lymphocytes, dendritic cells, NK cells), and genetic variants are strongly associated with susceptibility to several autoimmune diseases and neurodegenerative disorders[2][3][4]. The precise molecular pathways influenced by CLEC16A are being intensively studied, primarily regarding autophagy/mitophagy and antigen presentation, but no clinically approved drugs currently target CLEC16A directly.

Other names

CLEC16AKIAA0350Gop-1Protein CLEC16AC-type lectin domain family 16 member A

No drugs with established mechanisms of action directly targeting CLEC16A. Mechanistically, future drugs might: - Modulate CLEC16A's E3 ligase activity - Alter mitophagy or immune cell antigen presentation pathways - Correct dysfunctional mitochondrial clearance